Voyager Therapeutics (VYGR) Treasury Shares (2014 - 2026)

Voyager Therapeutics (VYGR) has 13 years of Treasury Shares data on file, last reported at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 25.99% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (down 25.99% YoY), and the FY2025 full-year result was $2.3 million, up 39.21% from the prior year.
• Treasury Shares retreated to $2.1 million in Q1 2026, from $2.3 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.8 million in Q1 2025 to a low of $941275.0 in Q3 2022.
• A 5-year average of $1.7 million and a median of $1.6 million in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares plunged 31.7% in 2022 and soared 65.72% in 2025, its largest moves.
• Tracing VYGR's Treasury Shares over 5 years: stood at $1.1 million in 2022, then rose by 23.22% to $1.4 million in 2023, then grew by 20.35% to $1.6 million in 2024, then soared by 39.21% to $2.3 million in 2025, then fell by 8.2% to $2.1 million in 2026.
• Business Quant data shows VYGR's Treasury Shares at $2.1 million in Q1 2026, $2.3 million in Q4 2025, and $2.5 million in Q3 2025.